Liansu raises $250 million, while WWTT withdraws IPO

The increasingly selective approach by investors also works in favour of Sino Biopharmaceutical which is able to raise $144 million from an upsized placement earlier this week.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES